{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T20:00:26Z","timestamp":1775160026978,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007959","name":"Chulabhorn Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007959","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["worldallergyorganizationjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Allergy Organization Journal"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.waojou.2019.100012","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T08:50:19Z","timestamp":1552035019000},"page":"100012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season"],"prefix":"10.1016","volume":"12","author":[{"given":"Ralph","family":"M\u00f6sges","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nils Y.","family":"Breitr\u00fcck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Allekotte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kija","family":"Shah-Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Van-Anh","family":"Dao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Zieglmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrin","family":"Birkholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maximilian","family":"Bastl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Bastl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias F.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Guethoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.waojou.2019.100012_bib1","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jaci.2015.07.038","article-title":"Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study","volume":"136","author":"Schmitt","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.waojou.2019.100012_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s40629-014-0032-2","volume":"23","author":"Pfaar","year":"2014","journal-title":"Allergo J Int"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib3","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jaci.2015.04.047","article-title":"International consensus on allergy immunotherapy","volume":"136","author":"Jutel","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40521-014-0037-6","article-title":"Allergen immunotherapy adherence in the real world: how bad is it and how can it Be improved?","volume":"2","author":"Senna","year":"2014","journal-title":"Curr Treat Options Allergy"},{"issue":"2","key":"10.1016\/j.waojou.2019.100012_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaci.2013.03.013","article-title":"Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy","volume":"132","author":"Kiel","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2019.100012_bib6","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11882-015-0586-1","article-title":"Adherence to sublingual immunotherapy","volume":"16","author":"Incorvaia","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib7","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2222.2012.04052.x","article-title":"Adherence to pharmacological treatment and specific immunotherapy in allergic rhinitis","volume":"43","author":"Passalacqua","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/imt.12.147","article-title":"A\u00a0causal treatment for grass pollen-induced allergic rhinoconjunctivitis","volume":"5","author":"K\u00f6berlein","year":"2012","journal-title":"Immunotherapy"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib9","first-page":"131","article-title":"Safety, tolerability and efficacy of sublingual allergoid immunotherapy with three different shortened up-dosing administration schedules","volume":"30","author":"Passali","year":"2010","journal-title":"Acta Otorhinolaryngol Ital"},{"issue":"2","key":"10.1016\/j.waojou.2019.100012_bib10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1398-9995.2005.00949.x","article-title":"Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis","volume":"61","author":"Dahl","year":"2006","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaip.2016.09.027","article-title":"Sublingual immunotherapy dosing regimens: what is ideal?","volume":"5","author":"Jin","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.waojou.2019.100012_bib12","series-title":"Guideline on Allergen Products, Production and Quality Issues","year":"2008"},{"issue":"4","key":"10.1016\/j.waojou.2019.100012_bib13","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/all.13357","article-title":"Allergen manufacturing and quality aspects for allergen immunotherapy in Europe and the United States: an analysis from the EAACI AIT Guidelines Project","volume":"73","author":"Bonertz","year":"2018","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2009.10.060","article-title":"Speaking the same language: the world allergy organization subcutaneous immunotherapy systemic reaction grading system","volume":"125","author":"Cox","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jaci.2013.03.039","article-title":"Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language","volume":"132","author":"Passalacqua","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100012_bib16","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1185\/03007991003659483","article-title":"Sublingual immunotherapy in daily medical practice: effectiveness of different treatment schedules - IPD meta-analysis","volume":"26","author":"Sieber","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"6","key":"10.1016\/j.waojou.2019.100012_bib17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/07853890.2011.595426","article-title":"Specific immunotherapy for allergic rhinitis to grass and tree pollens in daily medical practice-symptom load with sublingual immunotherapy compared to subcutaneous immunotherapy","volume":"43","author":"Sieber","year":"2011","journal-title":"Ann Med"},{"issue":"Suppl 86","key":"10.1016\/j.waojou.2019.100012_bib18","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1398-9995.2007.01620.x","article-title":"Allergic rhinitis and its Impact on asthma (ARIA) 2008 update (in collaboration with the world health organization, GA(2)LEN and AllerGen)","volume":"63","author":"Bousquet","year":"2008","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.waojou.2019.100012_bib19","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1111\/all.13362","article-title":"RCAT reflects symptom control and quality of life in allergic rhinoconjunctivitis patients","volume":"73","author":"Liedtke","year":"2018","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.waojou.2019.100012_bib20","first-page":"607","article-title":"Evaluation of efficacy and tolerability of a fixed combination of dry extracts of thyme herb and primrose root in adults suffering from acute bronchitis with productive cough. A prospective, double-blind, placebo-controlled multicentre clinical trial","volume":"57","author":"Kemmerich","year":"2007","journal-title":"Arzneimittelforschung"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib21","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10453-014-9326-6","article-title":"Development of a symptom load index: enabling temporal and regional pollen season comparisons and pointing out the need for personalized pollen information","volume":"30","author":"Bastl","year":"2014","journal-title":"Aerobiologia"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A\u00a0power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"key":"10.1016\/j.waojou.2019.100012_bib23","series-title":"Statistical Methods for Meta-Analysis","author":"Hedges","year":"1985"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib24","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/all.13066","article-title":"European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a real-life clinical assessment","volume":"72","author":"Calder\u00f3n","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib25","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pai.12660","article-title":"The European survey on adverse systemic reactions in allergen immunotherapy (EASSI): a paediatric assessment","volume":"28","author":"Rodriguez Del Rio","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2019.100012_bib26","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1081-1206(10)60003-8","article-title":"Accelerated immunotherapy schedules: review of efficacy and safety","volume":"97","author":"Cox","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"2","key":"10.1016\/j.waojou.2019.100012_bib27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.iac.2011.02.007","article-title":"Systemic reactions to subcutaneous allergen immunotherapy","volume":"31","author":"Bernstein","year":"2011","journal-title":"Immunol Allergy Clin N AM"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib28","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1081-1206(10)60088-9","article-title":"Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study","volume":"102","author":"Serrano","year":"2009","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaci.2005.05.005","article-title":"Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus","volume":"116","author":"Tabar","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib30","first-page":"155","article-title":"Dermatophagoides pteronyssinus cluster immunotherapy. A controlled trial of safety and clinical efficacy","volume":"9","author":"Tabar","year":"1999","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"4","key":"10.1016\/j.waojou.2019.100012_bib31","first-page":"221","article-title":"Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units","volume":"13","author":"Moreno","year":"2003","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib32","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000161585","article-title":"Safety and immunogenicity of a cluster specific immunotherapy in children with bronchial asthma and mite allergy","volume":"148","author":"Schubert","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000210436","article-title":"Safety of two cluster schedules for subcutaneous immunotherapy in allergic rhinitis or asthma patients sensitized to inhalant allergens","volume":"150","author":"Pfaar","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.waojou.2019.100012_bib34","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1365-2222.2008.02995.x","article-title":"Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment","volume":"38","author":"Subiza","year":"2008","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib35","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.alit.2018.03.008","article-title":"The global development and clinical efficacy of sublingual tablet immunotherapy for allergic diseases","volume":"67","author":"Nolte","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.waojou.2019.100012_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"issue":"3","key":"10.1016\/j.waojou.2019.100012_bib37","first-page":"3","article-title":"Carbamylated monomeric allergoids as a therapeutic option for sublingual immunotherapy of dust mite- and grass pollen-induced allergic rhinoconjunctivitis: a systematic review of published trials with a meta-analysis of treatment using Lais(R) tablets","volume":"19","author":"M\u00f6sges","year":"2010","journal-title":"Acta Dermatovenerol Alpina Pannonica Adriatica"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib38","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1398-9995.2008.01875.x","article-title":"Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study","volume":"64","author":"Ott","year":"2009","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-7022-4-7","article-title":"Sustained efficacy and safety of a 300IR daily dose of a sublingual solution of birch pollen allergen extract in adults with allergic rhinoconjunctivitis: results of a double-blind, placebo-controlled study","volume":"4","author":"Worm","year":"2014","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.waojou.2019.100012_bib40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/2045-7022-4-23","article-title":"A\u00a0prospective study comparing the efficacy and safety of two sublingual birch allergen preparations","volume":"4","author":"Klimek","year":"2014","journal-title":"Clin Transl Allergy"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib41","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/all.12760","article-title":"A\u00a0randomized DBPC trial to determine the optimal effective and safe dose of a SLIT-birch pollen extract for the treatment of allergic rhinitis: results of a phase II study","volume":"71","author":"Pfaar","year":"2016","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.waojou.2019.100012_bib42","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/ACI.0000000000000007","article-title":"Safety and tolerability of sublingual immunotherapy in clinical trials and real life","volume":"13","author":"Senna","year":"2013","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.waojou.2019.100012_bib43","series-title":"EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis","author":"Roberts","year":"2017"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40413-018-0203-6","article-title":"The connection of pollen concentrations and crowd-sourced symptom data: new insights from daily and seasonal symptom load index data from 2013 to 2017 in Vienna","volume":"11","author":"Bastl","year":"2018","journal-title":"World Allergy Organization Journal"},{"key":"10.1016\/j.waojou.2019.100012_bib45","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.scitotenv.2016.01.014","article-title":"First comparison of symptom data with allergen content (Bet v 1 and Phl p 5 measurements) and pollen data from four European regions during 2009-2011","volume":"548\u2013549","author":"Bastl","year":"2016","journal-title":"Sci Total Environ"},{"issue":"6","key":"10.1016\/j.waojou.2019.100012_bib46","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s12325-017-0535-6","article-title":"Management of grass pollen allergy with 5-grass pollen tablet: results of a 2-year real-life study","volume":"34","author":"Shah-Hosseini","year":"2017","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.waojou.2019.100012_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/all.13240","article-title":"Ultra-short-course booster is effective in recurrent grass pollen-induced allergic rhinoconjunctivitis","volume":"73","author":"Pfaar","year":"2018","journal-title":"Allergy"}],"container-title":["World Allergy Organization Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119300997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1939455119300997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:40:43Z","timestamp":1761849643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1939455119300997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["S1939455119300997"],"URL":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100012","relation":{},"ISSN":["1939-4551"],"issn-type":[{"value":"1939-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shortened up-dosing with sublingual immunotherapy drops containing tree allergens is well tolerated and elicits dose-dependent clinical effects during the first pollen season","name":"articletitle","label":"Article Title"},{"value":"World Allergy Organization Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.waojou.2019.100012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc. on behalf of World Allergy Organization.","name":"copyright","label":"Copyright"}],"article-number":"100012"}}